Published by mark itwired
Posted on August 10, 2021
6 min readLast updated: February 18, 2026
Add as preferred source on Google
The global biophotonics market is anticipated to witness an impressive growth of over 11.3% CAGR during the forecast period of 2021 and 2031, forecasts ESOMAR-certified consulting firm Future Market Insights.
Growing geriatric population and extensive use of biophotonics in cell and tissue diagnostics are the key factors propelling the market growth. Advent of nanotechnology in biophotonics and increasing application of biophotonics within light therapy and microscopy will improve the demand.
Biophotonics are extensively used in light therapy, as light therapy devices are acquiring center stage in the healthcare industry. Also, government support through funding and investment in medical diagnostics is improving the market demand.
Integration of detection, diagnosis, and staging during the time of endoscopy is providing growth opportunities for the market players. Significant developments in the field of see-through imaging techniques, especially in medical diagnostics and drug discovery, will improve the market demand.
Extensive usage of biophotonics endoscopic techniques, especially in providing functional and biochemical information in the application of medical therapeutics will drive the market growth.
Increasing geriatric population and rising prevalence of lifestyle diseases such as obesity, insomnia and others have improved the demand of light therapy in the field of medical therapeutics. This in turn will bolster the growth of biophotonics market.
According to FMI, the application of biophotonics in microscopy and light therapy will witness an impressive growth, exhibiting the demand of over 15% each respectively over the forecast period.
To remain ‘ahead’ of your competitors, request for a sample>>> https://www.futuremarketinsights.com/reports/sample/rep-gb-92
“Technological advancements and soaring demand within medical therapeutics and diagnostics for treating lifestyle diseases such as obesity and insomnia will drive the market demand. Catering the heightened demand, biophotonics manufacturers have increased the development by incorporating advanced technology, generating expansion prospects in the industry,” says the FMI analyst.
Key Takeaways from FMI’s Biophotonics Market Study
Competitive Landscape
Key players in the biophotonics market are focusing on new product launches for the expansion of their product portfolios.
Adoption of latest technology in the healthcare sector have enabled the advent of the new players, leading to a competitive market.
Prominent market players are forging alliances with other top healthcare companies to maintain their position in the industry.
For instance, in June 2021, Alberta Biophotonics Inc. announced the acquisition of additional shares of Flurotech Limited, pursuant to a three-cornered amalgamation between the FluroTech, FluroTest Systems Ltd. and 2330853 Alberta Ltd.
Recently, another key player PhotoniCare Inc. announced the funding of more than US$ 7 million to commercially expand its imaging technology, TOMi Scope.
In May 2021, Olympus America announced the launch and clearance of its BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, a new addition to its EBUS portfolio of devices for lung cancer diagnosis and staging via needle biopsy.
Increasing investment and funding for biomedical imaging and initiatives for research & development are providing lucrative opportunities for the market players.
For example, recently, the Chan Zuckerberg Initiative (CZI) announced a funding of nearly US$ 32 million for biomedical imaging research, technology development, and the Bio Imaging North America international network of bio imaging facilities & communities.
Some of the prominent market players profiled by Future Market Insights operating in biophotonics market include:
For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-92
More Insights on the Global Biophotonics Market
Future Market Insights, in its latest study of global biophotonics market offers an unbiased analysis on the market trends and drivers, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of:
Application
End Use
Region
Key Questions Covered in the Report
Buy Now@ https://www.futuremarketinsights.com/checkout/92
Explore FMI’s Extensive Coverage on Chemicals and materials Domain
Hydro fluorocarbon market: The global hydro fluorocarbon market report by FMI gives an in-depth insight on the future expansion prospects, trends and challenges that market is likely to face in the upcoming decade. Key statistics regarding key segments have been presented across prominent geographies, along with a detailed assessment of the market’s competitive landscape.
Hydrotalcite market: The hydrotalcite market study published by FMI offers a comprehensive analysis and focused views on major trends expected to provide shape to future growth prospects. The report provides detailed analysis of the significant drivers, trends, challenges and opportunities prevailing for the forthcoming decade across key geographies along with competitive landscape of the upcoming decade.
Hydroxyapatite market: Future Market Insights gives a detailed segmentation on the global hydroxyapatite market with upcoming market trends, challenges and future growth dynamics across key geographies and prominent segments. The report provides a holistic approach, mapping the competitive landscape with detailed analysis on established players, new entrants, and opportunities likely to prevail across the 2021-2031 decade.
The biophotonics market is anticipated to witness an impressive growth of over 11.3% CAGR during the forecast period of 2021 to 2031.
Key factors propelling the market growth include the growing geriatric population and extensive use of biophotonics in cell and tissue diagnostics.
Light therapy devices are acquiring center stage in the healthcare industry, significantly increasing the demand for biophotonics applications.
Government support through funding and investment in medical diagnostics is crucial for the growth of the biophotonics market.
Prominent market players include Alberta Biophotonics Inc., PhotoniCare Inc., and Olympus America, which are focusing on new product launches and technological advancements.
Explore more articles in the Research Reports category
